FB
TEVA icon

Fulton Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Fulton Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,754
Closed -$403K – 422
2016
Q3 		$403K Sell
8,754
-318
-4% -$16.6K 0.04% 290
2016
Q2 		$456K Buy
9,072
+367
+4% +$19.5K 0.04% 249
2016
Q1 		$465K Buy
8,705
+3,290
+61% +$193K 0.05% 246
2015
Q4 		$355K Sell
5,415
-108
-2% -$6.67K 0.04% 262
2015
Q3 		$312K Sell
5,523
-6,083
-52% -$394K 0.04% 272
2015
Q2 		$686K Buy
11,606
+96
+0.8% +$5.92K 0.07% 194
2015
Q1 		$717K Buy
11,510
+3,617
+46% +$210K 0.08% 193
2014
Q4 		$454K Buy
7,893
+216
+3% +$12K 0.05% 223
2014
Q3 		$413K Sell
7,677
-396
-5% -$21K 0.05% 223
2014
Q2 		$423K Sell
8,073
-54
-0.7% -$2.76K 0.05% 224
2014
Q1 		$429K Sell
8,127
-1,912
-19% -$88.4K 0.05% 213
2013
Q4 		$402K Sell
10,039
-633
-6% -$24.9K 0.05% 218
2013
Q3 		$403K Sell
10,672
-13,378
-56% -$522K 0.05% 225
2013
Q2 		$943K Buy
+24,050
New +$937K 0.12% 133

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Fulton Bank's TEVA Position: Q4 2016 in Review

Fulton Bank sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 8,754 shares — an estimated $403K sold.

Fulton Bank first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $943K in Q2 2013. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • Fulton Bank reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Fulton Bank sold 8,754 Teva Pharmaceuticals shares in Q4 2016, an estimated $403K.
  • Fulton Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Fulton Bank's Teva Pharmaceuticals position peaked at $943K in Q2 2013.
  • 737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Fulton Bank's 13F filing for Q4 2016, filed 5 Jan 2017.